A Efficacy and Safety Trial of Controlled Release (CR) Morphine in Cancer Patients

Summary

The purpose of the study is to determine the effect of Egalet® Morphine once daily compared to MST Continus twice daily on pain intensity and use of rescue medication for break through pain after 2 weeks of treatment in patients with pain due to cancer.

Timeline

Start

2007-08

Primary completion

2008-06

Completion

2008-08

Drugs

Indications